These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18008143)

  • 1. Inhibition of apoptosis, activation of NKT cell and upregulation of CD40 and CD40L mediated by M. leprae antigen(s) combined with Murabutide and Trat peptide in leprosy patients.
    Chattree V; Khanna N; Bisht V; Rao DN
    Mol Cell Biochem; 2008 Feb; 309(1-2):87-97. PubMed ID: 18008143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal delivery of Mycobacterium leprae antigen(s) with murabutide and Trat peptide inhibits Fas-mediated apoptosis of peripheral blood mononuclear cells derived from leprosy patients.
    Chattree V; Khanna N; Bisht V; Rao DN
    Indian J Biochem Biophys; 2007 Oct; 44(5):386-93. PubMed ID: 18341215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
    Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
    Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients.
    Chattree V; Khanna N; Rao DN
    Mol Immunol; 2007 Mar; 44(8):2066-77. PubMed ID: 17046060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy.
    Yamauchi PS; Bleharski JR; Uyemura K; Kim J; Sieling PA; Miller A; Brightbill H; Schlienger K; Rea TH; Modlin RL
    J Immunol; 2000 Aug; 165(3):1506-12. PubMed ID: 10903757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling lymphocytic activation molecule expression and regulation in human intracellular infection correlate with Th1 cytokine patterns.
    García VE; Quiroga MF; Ochoa MT; Ochoa L; Pasquinelli V; Fainboim L; Olivares LM; Valdez R; Sordelli DO; Aversa G; Modlin RL; Sieling PA
    J Immunol; 2001 Nov; 167(10):5719-24. PubMed ID: 11698444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of in vitro T cell responsiveness in lepromatous leprosy.
    Kaplan G; Weinstein DE; Steinman RM; Levis WR; Elvers U; Patarroyo ME; Cohn ZA
    J Exp Med; 1985 Sep; 162(3):917-29. PubMed ID: 3928804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and cytokine profile of monocyte derived dendritic cells in leprosy: in vitro stimulation by sonicated Mycobacterium leprae induces decreased level of IL-12p70 in lepromatous leprosy.
    Braga AF; Moretto DF; Gigliotti P; Peruchi M; Vilani-Moreno FR; Campanelli AP; Latini AC; Iyer A; Das PK; Souza VN
    Mem Inst Oswaldo Cruz; 2015 Aug; 110(5):655-61. PubMed ID: 26222022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal by interleukin-2 of the T cell unresponsiveness of lepromatous leprosy to Mycobacterium leprae.
    Haregewoin A; Mustafa AS; Helle I; Waters MF; Leiker DL; Godal T
    Immunol Rev; 1984 Aug; 80():77-86. PubMed ID: 6386665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients.
    Kaleab B; Ottenoff T; Converse P; Halapi E; Tadesse G; Rottenberg M; Kiessling R
    Eur J Immunol; 1990 Dec; 20(12):2651-9. PubMed ID: 2269329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens.
    Upadhyay R; Dua B; Sharma B; Natrajan M; Jain AK; Kithiganahalli Narayanaswamy B; Joshi B
    BMC Infect Dis; 2019 Jan; 19(1):52. PubMed ID: 30642265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between macrophage activation and bactericidal function and Mycobacterium leprae antigen presentation in macrophages of leprosy patients and normal individuals.
    Desai SD; Birdi TJ; Antia NH
    Infect Immun; 1989 Apr; 57(4):1311-7. PubMed ID: 2494115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.
    Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH
    Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.
    Macfarlane A; Mondragon-Gonzalez R; Vega-Lopez F; Wieles B; de Pena J; Rodriguez O; Suarez y de la Torre R; de Vries RR; Ottenhoff TH; Dockrell HM
    Clin Diagn Lab Immunol; 2001 May; 8(3):604-11. PubMed ID: 11329466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of cytokine response against panel of purified Mycobacterium leprae antigens by using whole blood assay in subjects residing in a resettlement village of cured leprosy patients.
    Kamble RR; Shinde VS; Madhale SP; Jadhav RS
    Indian J Lepr; 2010; 82(1):23-31. PubMed ID: 21229844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.